BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
15.85
-0.12 (-0.75%)
At close: Sep 5, 2025, 4:00 PM
16.16
+0.31 (1.96%)
After-hours: Sep 5, 2025, 5:38 PM EDT
BrainsWay Market Cap
BrainsWay has a market cap or net worth of $294.83 million as of September 5, 2025. Its market cap has increased by 126.94% in one year.
Market Cap
294.83M
Enterprise Value
222.33M
1-Year Change
126.94%
Ranking
Category
Stock Price
$15.85
Market Cap Chart
Since September 3, 2013, BrainsWay's market cap has increased from $178.92M to $294.83M, an increase of 64.78%. That is a compound annual growth rate of 4.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 295.54M | 63.85% |
| Dec 31, 2024 | 180.37M | 70.88% |
| Dec 31, 2023 | 105.55M | 216.46% |
| Dec 29, 2022 | 33.35M | -73.96% |
| Dec 30, 2021 | 128.06M | 62.02% |
| Dec 31, 2020 | 79.04M | -26.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |